person

Robert K.

Country
Germany
Department
Clinic for Angiology/Hemostaseology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
53
Sites with multiple studies

Has run more than one trial at 53 of 115 partner sites.

Specializations

Hemophilia Research Focus

This investigator specializes in pioneering treatments for hemophilia A and B, with particular emphasis on developing innovative gene therapy approaches for patients with severe and moderately severe forms of the condition.

  • AAV-based gene therapies
  • Factor IX expression studies
  • Long-term safety assessments

The research extends to evaluating subcutaneous prophylactic treatments and novel therapeutic proteins for bleeding prevention.

Blood Coagulation Disorders

The investigator conducts research in congenital blood disorders, focusing on treatments for patients with antithrombin deficiency, particularly in surgical and obstetric contexts.

  • Thrombotic event prevention
  • Perioperative management
  • Pregnancy-related complications

Their work includes evaluation of targeted therapies for managing complex coagulation disorders during high-risk procedures.

Advanced Therapeutic Applications

The investigator explores systemic administration techniques for genetic therapies and investigates novel biological compounds for treating hereditary bleeding disorders.

  • Vector-based delivery systems
  • Coagulation factor replacement
  • Prophylactic treatment strategies

Research activities encompass both traditional and innovative therapeutic approaches for managing chronic blood disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.